Cerwinka Wolfgang H, Qian Jing, Easley Kirk A, Scherz Hal C, Kirsch Andrew J
Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
J Urol. 2009 Mar;181(3):1324-8; discussion 1329. doi: 10.1016/j.juro.2008.11.036. Epub 2009 Jan 20.
With the increasing popularity of endoscopic treatment for vesicoureteral reflux in children, dextranomer/hyaluronic acid copolymer implants are more frequently detected on computerized tomography, which may lead to misinterpretation and unnecessary intervention. The objective of this study was to characterize the long-term appearance of dextranomer/hyaluronic acid copolymer implants on computerized tomography.
We evaluated the hospital charts of 893 patients who had undergone dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux between July 2001 and November 2007 to identify those who underwent subsequent computerized tomography of the abdomen and pelvis. A total of 30 patients with ureterovesical junction stones served as the control group. Seven patients who proceeded to extravesical reimplantation after failed endoscopic treatment had dextranomer/hyaluronic acid copolymer implants explanted and microscopically evaluated.
Of 893 patients who had undergone endoscopic treatment for vesicoureteral reflux 17 (1.9%) underwent subsequent computerized tomography. A total of 33 dextranomer/hyaluronic acid copolymer implants were detected on computerized tomography, and were classified as low density (21) or high density (12). Median density was 22 HU (range 15 to 27) for low density implants and 193 HU (126 to 367) for high density implants. Radiograph of the kidneys, ureters and bladder, and fluoroscopy did not visualize high density implants. Neither gender, age at endoscopic treatment, vesicoureteral reflux grade, hydrodistention grade, injection volume, success nor second injection was associated with a high density implant. Only elapsed time between surgery and computerized tomography was associated with increased implant density (p = 0.02).
Dextranomer/hyaluronic acid copolymer implants may be encountered on computerized tomography as low or high density lesions. History of vesicoureteral reflux and absence of hydronephrosis as well as hematuria should provide reassurance and prevent inappropriate intervention for misdiagnosed ureteral stones.
随着儿童膀胱输尿管反流内镜治疗的日益普及,葡聚糖omer/透明质酸共聚物植入物在计算机断层扫描中更频繁地被检测到,这可能导致误诊和不必要的干预。本研究的目的是描述葡聚糖omer/透明质酸共聚物植入物在计算机断层扫描中的长期表现。
我们评估了2001年7月至2007年11月期间接受葡聚糖omer/透明质酸共聚物注射治疗膀胱输尿管反流的893例患者的医院病历,以确定那些随后接受腹部和盆腔计算机断层扫描的患者。共有30例输尿管膀胱连接部结石患者作为对照组。7例内镜治疗失败后进行膀胱外再植的患者,其葡聚糖omer/透明质酸共聚物植入物被取出并进行显微镜评估。
在893例接受膀胱输尿管反流内镜治疗的患者中,17例(1.9%)随后接受了计算机断层扫描。计算机断层扫描共检测到33个葡聚糖omer/透明质酸共聚物植入物,分为低密度(21个)或高密度(12个)。低密度植入物的中位密度为22 HU(范围15至27),高密度植入物的中位密度为193 HU(126至367)。肾脏、输尿管和膀胱的X线片以及荧光透视均未显示高密度植入物。性别、内镜治疗时的年龄、膀胱输尿管反流分级、水扩张分级、注射量、治疗成功与否以及二次注射均与高密度植入物无关。只有手术与计算机断层扫描之间的时间间隔与植入物密度增加有关(p = 0.02)。
葡聚糖omer/透明质酸共聚物植入物在计算机断层扫描中可能表现为低密度或高密度病变。膀胱输尿管反流病史、无肾积水以及血尿应能提供 reassurance 并防止对误诊为输尿管结石的不当干预。 (注:“reassurance”此处结合语境大概是“安心、消除疑虑”之意,但按要求未做解释)